Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
Title:
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
Author:
Winston, D.J. Saliba, F. Blumberg, E. Abouljoud, M. Garcia-Diaz, J.B. Goss, J.A. Clough, L. Avery, R. Limaye, A.P. Ericzon, B.G. Navasa, M. Troisi, R.I. Chen, H. Villano, S.A. Uknis, M.E.
Appeared in:
American journal of transplantation
Paging:
Volume 12 () nr. 11 pages 3021-3030
Year:
2012
Contents:
Publisher:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.